Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2000 1
2001 1
2002 1
2003 3
2004 5
2005 2
2006 4
2007 4
2008 5
2009 7
2010 13
2011 13
2012 8
2013 5
2014 8
2015 4
2016 6
2017 4
2018 11
2019 2
2020 9
2021 10
2022 8
2023 12
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

132 results

Results by year

Filters applied: . Clear all
Page 1
From structure to clinic: Design of a muscarinic M1 receptor agonist with potential to treatment of Alzheimer's disease.
Brown AJH, Bradley SJ, Marshall FH, Brown GA, Bennett KA, Brown J, Cansfield JE, Cross DM, de Graaf C, Hudson BD, Dwomoh L, Dias JM, Errey JC, Hurrell E, Liptrot J, Mattedi G, Molloy C, Nathan PJ, Okrasa K, Osborne G, Patel JC, Pickworth M, Robertson N, Shahabi S, Bundgaard C, Phillips K, Broad LM, Goonawardena AV, Morairty SR, Browning M, Perini F, Dawson GR, Deakin JFW, Smith RT, Sexton PM, Warneck J, Vinson M, Tasker T, Tehan BG, Teobald B, Christopoulos A, Langmead CJ, Jazayeri A, Cooke RM, Rucktooa P, Congreve MS, Weir M, Tobin AB. Brown AJH, et al. Among authors: langmead cj. Cell. 2021 Nov 24;184(24):5886-5901.e22. doi: 10.1016/j.cell.2021.11.001. Cell. 2021. PMID: 34822784 Free PMC article. Clinical Trial.
Differential GLP-1R Binding and Activation by Peptide and Non-peptide Agonists.
Zhang X, Belousoff MJ, Zhao P, Kooistra AJ, Truong TT, Ang SY, Underwood CR, Egebjerg T, Šenel P, Stewart GD, Liang YL, Glukhova A, Venugopal H, Christopoulos A, Furness SGB, Miller LJ, Reedtz-Runge S, Langmead CJ, Gloriam DE, Danev R, Sexton PM, Wootten D. Zhang X, et al. Among authors: langmead cj. Mol Cell. 2020 Nov 5;80(3):485-500.e7. doi: 10.1016/j.molcel.2020.09.020. Epub 2020 Oct 6. Mol Cell. 2020. PMID: 33027691 Free article.
Molecular pharmacology of GPCRs.
Langmead CJ, Summers RJ. Langmead CJ, et al. Br J Pharmacol. 2018 Nov;175(21):4005-4008. doi: 10.1111/bph.14474. Br J Pharmacol. 2018. PMID: 30302756 Free PMC article.
Langmead CJ. Langmead CJ. Adv Pharmacol. 2020;88:xiii-xvii. doi: 10.1016/S1054-3589(20)30037-5. Adv Pharmacol. 2020. PMID: 32416874 No abstract available.
Generative models of conformational dynamics.
Langmead CJ. Langmead CJ. Adv Exp Med Biol. 2014;805:87-105. doi: 10.1007/978-3-319-02970-2_4. Adv Exp Med Biol. 2014. PMID: 24446358 Free PMC article. Review.
G protein-coupled receptors as anabolic drug targets in osteoporosis.
Diepenhorst N, Rueda P, Cook AE, Pastoureau P, Sabatini M, Langmead CJ. Diepenhorst N, et al. Among authors: langmead cj. Pharmacol Ther. 2018 Apr;184:1-12. doi: 10.1016/j.pharmthera.2017.10.015. Epub 2017 Nov 7. Pharmacol Ther. 2018. PMID: 29080701 Review.
Recent advances in generative biology for biotherapeutic discovery.
Mock M, Langmead CJ, Grandsard P, Edavettal S, Russell A. Mock M, et al. Among authors: langmead cj. Trends Pharmacol Sci. 2024 Mar;45(3):255-267. doi: 10.1016/ Epub 2024 Feb 19. Trends Pharmacol Sci. 2024. PMID: 38378385 Free article. Review.
132 results